| Vol. 1 Issue 02 Friday, January 4, 2008 |
 |
Commercial Scale Antitubercular Pyrazinamide Isoniazid Rifampicin Antimalarial Artesunate Arteether Artemether Dihydroartemisinin Macrolides Azithromycin Erythromycin base Erythromycin estolate Erythromycin ethylsuccinate Erythromycin oxime (intermediate) Erythromycin phosphate Erythromycin propionate Erythromycin stearate Roxithromycin Antihypertensive Lisinopril dihydrate Losartan potassium Antiepileptic Sodium valproate Valproic acid Antiosteoporotic Alendronate sodium Zoledronic acid Sedative, Hypnotic Zopiclone Antidepressant Venlafaxine hydrochloride Antihistaminic Cetirizine dihydrochloride Antithrombotic Clopidogrel bisulphate Pilot Plant Scale Carvedilol Clarithromycin Pioglitazone hydrochloride Rosiglitazone maleate Valsartan R & D Scale Lumefantrine Pamidronate disodium Perindopril erbumine Zolpidem tartrate Development Benazepril hydrochloride Candesartan Desvenlafaxine Glipizide Irbesartan Levocetirizine Ramipril Rifabutin Rifapentine Risedronic acid Telmisartan
|
||
IDMA honours Calyx with Quality Excellence Award 2007 We take pride to announce to our readers that CALYX has won the “Quality Excellence Awards 2007 - Silver Award – In the category of Bulk Drug Units – annual turnover above Rs. 100 crores (Above US$ 25 Millions)” This Award, instituted by IDMA will be presented to CALYX during the 46th Annual Day Celebrations of IDMA (Indian Drug Manufacturers’ Association) which would be held on Friday, 11th January 2008 at 6.30 p.m. at Hotel Hyatt Regency, Sahar, Mumbai, India. About
IDMA (Indian Drug Manufacturers’ Association) In
order to promote and help the growth of the national pharmaceutical
industry, IDMA has instituted various Awards. One of
the awards is the IDMA GOLD, SILVER AND MERIT QUALITY EXCELLENCE
AWARDS. |
|||
|
We could achieve this Quality Excellence Award because of your valued suggestions and support. Hence we owe this award to our valued customers. We are constantly sensing our customers’ needs and striving to be an integral part of their growth. To strengthen our QA activities, we train our people regularly to upgrade their knowledge & skill-set. We continuously upgrade our quality system to comply with the latest and the best in the industry. This has helped us comply with requirements of regulatory authorities and our customers. We have successfully complied with the audits by WHO (Geneva), EDQM & US FDA. We are certified by Bureau Veritas for ISO 9001:2000 for Quality Management System and our challenge for the new millennium is to learn how to live in harmony with the environment. We look at Environment, Health & Safety (EHS) excellence as competitive advantage in today’s business scenario. Due to our efforts and commitment, we are certified by Bureau Veritas for ISO 14001:2004, an Environment Management System. |
|||
|
|||
|
|||
| Disclaimer: "The information in this e-mail and any attachments is confidential and may be legally privileged. It is intended solely for the addressee or addressees. If you are not an intended recipient, please delete the message and any attachments and notify the sender of misdelivery. Any use or disclosure of the contents of either is unauthorized and may be unlawful. All liability for viruses is excluded to the fullest extent permitted by law. Any views expressed in this message are those of the individual sender, except where the sender states them, with requisite authority, to be those of the specific Calyx company." |
|||
| To unsubscribe from this Newsletter send blank email to pharmanews@calyxindia.com | |||
| "Meet
us at ‘InformexUSA 2008’ at Morial Convention Centre,
New Orleans, Louisiana January 29 – February 1, 2008, at Booth 1707” |
|||
 |
|||
